Thank you for sharing that information with all of us. Wow, that is alarming…I must admit that after reading your post I am shocked and confused. It makes me nervous, having invested, what is, to me, a good bit of money in this stock/company. I have always felt really good about this stock, but after reading this I don't know what to think! Again, thank you.
My understanding was that after the April email from Dr Berman, ESSI notified someone else via email publicly posted, that the company teamed up with another research group and trials were started and due to be completed around the end of September. Results should be know either by then or right after. I believe if you go into the original data on the company, that Berman was contracted and is on contract until late this year and then I think she is done. If as she says this product was being used almost 10 years ago, and it is a known product, I cannot reasonably believe that there would be any hesitation in this product moving forward. I'm surprised that it isn't already being formulated and tested in other countries and/or as a homeopathic topical substance etc. The CEO of this company hasn't done their investors nor themselves any good by their lack of communication in where they stand and what the goals and expectations are. I had hoped to see some PR from them this past month but - crickets. Here's hoping someone is back from vacation, rolling their sleeves up and getting down to business.
News 
Market Data 
Discover 
AI
